These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6174653)

  • 21. [Intralymphatic treatment of lymph-node metastases with Lipiodol labeled with I-131, with special reference to malignant melanoma].
    Edwards JM
    Minerva Med; 1967 Dec; 58(99):4512-3. PubMed ID: 4295505
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anti-tumor activity of zinostatin stimalamer (YM 881) examined by human hepatoma cells in vitro and VX2 liver tumor in vivo].
    Tanaka S; Fujihara A; Yamamoto M; Asano M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):219-26. PubMed ID: 8311492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body distribution of Lipiodol 131-J following intralymphatic radiotherapy.
    Fava G; Roncoroni L
    Nucl Med (Stuttg); 1965 Dec; 5(1):1-11. PubMed ID: 4287956
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fate of lipiodol injected by intravenous or lymphatic route. Histological modifications following these injections].
    Dalion J; Guerbet M; Delaville A
    Therapie; 1965; 20(3):789-96. PubMed ID: 4284652
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeted vinblastine chemotherapy with two preparations of lipiodol contrast medium.
    Oda T; Konno T; Nagamitsu A; Tabaru K; Maeda H; Kitamura N
    Anticancer Res; 1997; 17(5A):3521-9. PubMed ID: 9413197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution and consequences of cell suspensions following intralymphatic infusion.
    Juillard GJ; Boyer PJ; Niewisch H; Hom M
    Bull Cancer; 1979; 66(3):217-28. PubMed ID: 486731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental study on the mediastinal lymphangiography and intralymphatic chemotherapy].
    Mitani N
    Igaku Kenkyu; 1983 Dec; 53(6):376-96. PubMed ID: 6206678
    [No Abstract]   [Full Text] [Related]  

  • 28. [Endolymphatic therapy with labelled lipiodol--initial experiences].
    Hennig K; Franke WG; Platzbecker H; Herzmann H; Boelke L
    Radiobiol Radiother (Berl); 1970; 11(3):277-87. PubMed ID: 4323834
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chemical properties and tumor affinity of separated isomers of cobalt-bleomycin (author's transl)].
    Kakinuma J; Samezima K; Nakamura K; Kawaguchi H; Komine K; Orii H
    Kaku Igaku; 1981 Jul; 18(6):835-9. PubMed ID: 6171664
    [No Abstract]   [Full Text] [Related]  

  • 30. [Histological changes of the lymph nodes during radiant lymphography].
    Accinelli G; Ragni N; Rugiati S
    Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1463-72. PubMed ID: 4314290
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental and clinical studies on topical application of bleomycin in advanced esophageal cancer (author's transl)].
    Okudaira Y
    Fukuoka Igaku Zasshi; 1978 Apr; 69(4):127-45. PubMed ID: 78880
    [No Abstract]   [Full Text] [Related]  

  • 32. [An experimental study on the anti-cancer effects of bleomycin, depot bleomycin in oil and peplomycin (author's transl)].
    Kaneda T; Fujimoto Y; Ueda M; Shikimori M; Taguchi N; Hiraiwa K
    Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1303-9. PubMed ID: 6174651
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective effect of doxorubicin suspended in lipiodol on VX2 carcinoma in rabbits.
    Furuta T; Kanematsu T; Kakizoe S; Sugimachi K
    J Surg Oncol; 1988 Dec; 39(4):229-34. PubMed ID: 2848154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of iodized oil within the liver after hepatic arterial injection.
    Miller DL; O'Leary TJ; Girton M
    Radiology; 1987 Mar; 162(3):849-52. PubMed ID: 3027747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of zinostatin stimalamer (YM881) in human hepatoma cell lines and VX2 liver tumor-bearing rabbits.
    Tanaka S; Fujihara A; Yamamoto M; Ida H; Ohmi Y; Kitazaki T; Kikuchi Y; Yoshida S; Okamiya H; Numasaki Y; Konno T
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):155-63. PubMed ID: 8774069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Percutaneous injection of cisplatin lipiodol suspension (CLS) in rabbit lung, aiming at intratumoral injection therapy for lung cancer].
    Onohara S; Nakajo M; Abeyama K; Shinmaki H; Sagara K; Mukai H; Uchiyama N; Miyaji N; Harada O; Hiraki Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Oct; 52(10):1433-42. PubMed ID: 1333070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boron-lipiodol: a potential new drug for the treatment of liver tumors.
    Lin WY; Chi CW; Ho YJ; Wu IC; Chung YT; Chen SD; Chou FI; Kai JJ; Lui WY; Chen TJ; Lin Y
    Anticancer Res; 2002; 22(6C):3989-92. PubMed ID: 12553023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental studies on the lymph-node metastasis in carcinoma of the esophagus (author's transl)].
    Mine H
    Fukuoka Igaku Zasshi; 1980 Mar; 71(3):137-56. PubMed ID: 7380383
    [No Abstract]   [Full Text] [Related]  

  • 39. [EXPERIMENTAL ANNOTATIONS ON THE INTRODUCTION OF DRUGS THROUGH THE LYMPHATIC SYSTEM].
    GOFFRINI P
    G Ital Chir; 1964 May; 20():273-85. PubMed ID: 14236855
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on absorption, excretion and organ distrubition of bleomycin oil suspension (author's transl)].
    Abe F; Tsubosaki M; Tanaka T; Kato Y; Yoshioka O
    Jpn J Antibiot; 1976 Sep; 29(9):826-33. PubMed ID: 61291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.